BioIQ Scores Venture Capital

At-Home Diagnostics for Individuals and Companies

Santa Barbara-based BioIQ announced that it secured $2.5 million in growth capital (Series B financing) primarily through the venture firm Great Pacific Capital, whose managing partner, Dave Gross, will now take a seat on the company’s board. BioIQ produces biometric tools that allow individuals to self-screen for chronic conditions including diabetes, cancer, and heart disease. The in-home consumer-friendly kits’ major market currently is corporate: Employees submit information anonymously to their employer, who can then tailor health plans employees’ needs. More kits may also be marketed in the future directly to consumers. Among other benefits, this would allow people to detect conditions—even before they experience symptoms—without creating a record that might disqualify them from obtaining health insurance.

To submit a comment on this article, email or visit our Facebook page. To submit information to a reporter, email

Be succinct, constructive, and relevant to the story. Leaving a comment means you agree to our Discussion Guidelines. We like civilized discourse. We don't like spam, lying, profanity, harassment or personal attacks.

comments powered by Disqus
event calendar sponsored by:

Lavagnino’s Sudden Victory

5th District supervisor a shoo-in as filing window closes; Gregg Hart also unopposed for 2nd District.

One Half of Old Town Streets to Get Sidewalks

Walkways planned for one side of Goleta neighborhood streets; parking, lighting talks at community meeting March 22.

After Disaster in Montecito, Where Is All the Money Going?

Santa Barbara nonprofits account for millions spent on relief efforts.

Santa Barbara Experiences a Rainy March, but a Dry Year

Water year only 34 percent of normal for precipitation.

City Says Franceschi House Has Got to Go

The estimate to rehabilitate the historical building was nearly $7 million.